2026年5月4日
Wuhan Heyuan Biotech Anti-HPV Dressing Officially Approved for Market Launch
Warm Congratulations! Our Company’s Anti-Human Papillomavirus (HPV) Biological Protein Dressing Obtains National Medical Device Registration Certificate!
Recently, Wuhan Heyuan Biotechnology Co., Ltd. has officially received the Medical Device Registration Certificate of the People’s Republic of China issued by the Hubei Provincial Medical Products Administration (Registration Certificate No.: E Medical Device Approval 20252185909). This marks that our independently developed Anti-Human Papillomavirus (HPV) Biological Protein Dressing has officially passed national authoritative certification and been approved for market launch.
About the Approved Product
The newly approved Anti-HPV Biological Protein Dressing is a core product independently developed by our company after long-term technical research, focusing on the women’s health sector.
The product consists of two parts: gel and applicator. The gel is formulated with anhydridized bovine β-lactoglobulin, carbomer, glycerin, 4-hydroxyacetophenone, triethanolamine, 1,2-hexanediol and purified water. The applicator is made of medical-grade polypropylene material, ensuring safety and reliability.
The product is indicated for reducing local HPV viral load, providing a compliant and effective intervention option for relevant populations. It is available in multiple specifications: 2.0g/unit, 2.5g/unit, 3.0g/unit, 3.5g/unit, 4.0g/unit, 4.5g/unit and 5.0g/unit, meeting the needs of diverse clinical scenarios.
R&D Process & Significance
Since the project launch, the company’s R&D team has adhered to rigorous scientific standards and a high-standard quality management system. After going through multiple key stages including formula optimization, process verification and quality control, the product successfully passed review and approval and obtained the medical device registration certificate.
The approval of this registration certificate represents authoritative recognition from regulatory authorities of our company’s R&D strength, production capacity and quality control system. It also marks a major milestone for Heyuan Biotechnology in the field of HPV-related health products, laying a solid foundation for subsequent market promotion and clinical application.
Future Outlook
Moving forward, Wuhan Heyuan Biotechnology Co., Ltd. will continue to uphold the philosophy of “Technology Guards Health, Innovation Leads the Future”. We will further deepen our layout in the women’s health industry, deliver safer and more effective products to the society, and provide high-quality health solutions for users worldwide.
Wuhan Heyuan Biotechnology Co., Ltd.
December 11, 2025